Drug search by name

Baricitinib and Hyperlipemia

Result of checking the interaction of drug Baricitinib and disease Hyperlipemia for safety when used together.

Check result:

Baricitinib <> Hyperlipemia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

In controlled clinical trials, baricitinib treatment was associated with dose-related increases in lipid parameters including total cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol. It is recommended to evaluate lipid parameters at baseline and approximately 12 weeks following initiation of treatment. Manage patients according to clinical guidelines for the management of hyperlipidemia.

Baricitinib

Generic Name: baricitinib

Brand Name: Olumiant

Synonyms: n.a.

What is Baricitinib?